Delivery Order SPE2DB20D3101-SPE2DB23FRDY2

Award Date 3/1/23
Potential Completion Date 3/2/23
Potential Value $47K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $39,495.26, is for the supply of STELARA 90 MG/ML syringes. The contract has an ultimate completion date of May 18, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Stelara 90 mg/ml syringes. The contract has a ceiling value of $27,325.42 and an ultimate completion date of May 4, 2023. It is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the...
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Stelara 90 mg/ml syringes. The $35,689.73 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of January 13, 2023. The contract is not set-aside and is being executed as part of Cencora's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 2025, for...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $14,431.22, is for the supply of Stelara 90 mg/ml syringes. This delivery order is part of a larger IDC with the DLA, valued at up to $999,999,999.00, which covers a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,982.87 for the supply of STELARA 90 MG/ML SYRINGEML. The award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a civilian agency within the Department of Defense. The contract has an ultimate completion date of December 6, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition....
This federal contract award, valued at $34,467.56, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Stelara 90 mg/ml syringes, a specialty pharmaceutical product. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 4563942631 STELARA 45 MG/0.5 ML SYRINGE 0.5ML. The $12,439.97 Firm Fixed Price delivery order contract has a completion date of March 13, 2024. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $16,132.65 delivery order contract is for the supply of STELARA 90 MG/ML syringes. The contract is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, to support federal healthcare programs, particularly military and veterans' healthcare systems. The ceiling value of this delivery order is $18,625.00 and has a period of performance through April 18, 2023. This contract is part of a...
This federal contract award, valued at $79,956.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product, with a completion date of February 27, 2023. The contract is a Delivery Order issued under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRDY2
    Delivery Order

This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The delivery order, valued at $46,627.32, is for the provision of Stelara 90 mg/ml syringes. The contract is a firm-fixed-price delivery order with a completion date of March 2, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as a vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs. This delivery order was awarded through full and open competition without any set-aside designation.

Generated 2/27/25, 10:42 AM